ACSR and Proscia Concentriq on the Web
We are thrilled to announce ACSR’s highly valued relationship with Proscia®. Read the full release below for more on how enterprise digital pathology thru Proscia Concentriq is helping the ACSR …
NCI DCEG Research Summary: Anal Cancer Risk and Survival in People with HIV
The National Cancer Institute’s Division of Cancer Epidemiology and Genetics released a summary of 3 studies that have the potential for informing recommendations for anal cancer screening, the importance of …
NEW from NCI Minute: ComboMatch
Learn more about ComboMATCH: the new clinical trial initiative to evaluate combinations of treatments that block both the drivers of tumor growth and the mechanisms of resistance. The primary goal for ComboMATCH …
World AIDS Day@35: “Let us finish the fight”
The ACSR shares the same goal as millions around the world—to end the HIV epidemic. It will take a global effort, and we remain committed to supporting HIV/AIDS malignancy research to …